Reporter assays are commonly used for high-throughput cell-based screening of compounds, cDNAs, and siRNAs due to robust signal, ease of miniaturization, and simple detection and analysis. Among the most widely used reporter genes is the bioluminescent enzyme luciferase, which, when exposed to its substrate luciferin upon cell lysis, yields linear signal over a dynamic range of several orders of magnitude. Commercially available luciferase assay formulations have been developed permitting homogeneous, single-step cell lysis and reporter activity measurements. Assay conditions employed with these formulations are typically designed to minimize well-to-well luminescence variability due to variability in dispensing, evaporation, and incomplete sample mixing. The authors demonstrate that incorporating a microplate orbital mixing step into 96-and 384-well microplate cell-based luciferase reporter assays can greatly improve reporter readouts. They have found that orbital mixing using commercially available mixers facilitates maximal luciferase signal generation from high cell density-containing samples while minimizing variability due to partial cell lysis, thereby improving assay precision. The authors fully expect that widespread availability of mixers with sufficiently small orbits and higher speed settings will permit gains in signal and precision in the 1536-well format as well. (Journal of Biomolecular
INTRODUCTION
C ELL-BASED REPORTER TECHNOLOGIES have played a predominant role in driving postgenomic biomedical research and drug discovery due to their robust utility for quantitatively monitoring a broad range of activities, including gene expression and regulation, signal transduction events, protein-protein interactions, subcellular localization and trafficking, cell metabolism, cell proliferation and cytotoxicity, and compound screening. [1] [2] [3] [4] Among the most widely used reporter genes is that encoding the bioluminescent enzyme, luciferase, derived from the firefly Photinus pyralis. [5] [6] [7] [8] Synthesized as a catalytically competent monomer with a short, approximately 3-h half-life when expressed in mammalian cells, this enzyme facilitates adenosine triphosphate (ATP)-dependent oxidative decarboxylation of its substrate, luciferin, with concomitant light production. 9, 10 Moreover, the extraordinary quantum yield (> 88%) of the firefly luciferase reaction gives rise to a highly sensitive reporter with a linear dynamic range of greater than 7 orders of magnitude. 10, 11 The primary drawback of the luciferase system is that its substrate luciferin does not enter cells efficiently, thereby necessitating a cell lysis step to permit exposure of the luciferase reporter to its substrate.
Several groups have addressed this problem by developing effective cell lysis formulations and coupling them to optimized luciferase reaction conditions to generate homogeneous assay solutions (e.g., Bright-Glo™ and Steady-Glo™ from Promega, Madison, WI; Britelite™, Luclite ® , and Steadylite HTS™ from PerkinElmer, Boston, MA; Luc-Screen ® from Applied Biosystems, Foster City, CA; SuperLight™ from BioAssay Systems, Hayward, CA). [12] [13] [14] Furthermore, because these reagents can be directly added to samples without removal of the growth medium, these solutions enable simple, single-step luciferase activity measurements that are especially well suited to high-throughput microplate applications. Although the homogeneous assay concentrations are designed to minimize well-towell luminescence variations, in this report we demonstrate that inclusion of a microplate orbital mixing step following reagent addition in 96-and 384-well formats markedly improves highthroughput cell-based luciferase reporter assay readouts, particularly for the common assay endpoint scenario in which the adherent cells have become confluent. We conclude, based on these findings, that standard lysis conditions do not achieve complete cell lysis at high cell densities and that even at moderate cell densities, well-to-well signal variance can be reduced by ensuring complete lysis through microplate mixing.
METHODS AND MATERIALS
To examine the effects of microplate orbital mixing on reporter assay outcome, we first generated a stably expressing luciferase cell line by cotransfecting the mouse embryonic fibroblast cell line, NIH 3T3, with a puromycin resistance marker and the luciferase control reporter pGL3-Control (Promega, Madison, WI), which contains SV40 promoter and enhancer sequences to yield strong, constitutive, firefly luciferase expression in mammalian cells. Clonally selected NIH 3T3 cells stably expressing luciferase were cultured using standard conditions in Dulbecco's modified Eagle's medium (DMEM; Sigma, St. Louis, MO) supplemented with 10% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA) and puromycin. The use of a clonal cell line stably expressing luciferase enabled us to assume that under optimal conditions, luciferase signal should scale linearly with cell numbers because the cells are clonal in nature and express luciferase endogenously, in contrast to the more complicated scenario employing transient transfection of the reporter where variables such as transfection efficiency could reduce the precision of our measurements.
We then seeded individual 96-well and 384-well plates with 4 different starting cell concentrations to yield wells with increasing degrees of confluence, ranging from low (~10%-15%), moderate (~25%-30%), medium (~50%-60%), and high (~100%) confluence. Following an overnight incubation of 16 to 19 h to provide sufficient time for the cells to adhere to the microplates, yet not so long as to allow for significant proliferation to occur, cells were lysed and assayed for luciferase activity using one of the commonly employed homogeneous luciferase assay reagents, Britelite™. Britelite™, like its widely used counterpart, Bright-Glo™, is formulated to enable high luciferase signal intensity with an approximate half-life of 30 min. Because the luciferase reaction itself occurs almost instantaneously in the presence of its substrate luciferin and ATP, the rate-limiting step in most cellbased luciferase assays is lysis of the cells to release the sequestered luciferase molecules into solution. 10, 13 Accordingly, the manufacturers' protocols for both Britelite™ and Bright-Glo™ recommend waiting at least a minute or 2 following reagent addition to allow lysis to occur prior to performing luminescence measurements. To avoid the possibility of artifacts arising due to specific timing of measurements, we elected to monitor the progression of the microplate luciferase assays by reading each plate at several time points following addition of Britelite™ to the wells. Although 1 set of plates was processed as recommended in the standard Britelite™ protocol, by adding reagent and letting the plates incubate at room temperature between reads, a second set of plates was mixed immediately after reagent addition for 1 min using an HT-91002 Microplate Orbital Shaker (Big Bear Automation, Pleasanton, CA) with a 1-mm orbital motion. For 96-well plates, 1500 rotations per minute (rpm) was found to be optimal (data not shown). For 384-well plates, 2500 rpm was found to be optimal (data not shown). After mixing, all plates were read using a CLIPR™ 96/384/1536-well plate reader (Molecular Dynamics, Sunnyvale, CA). To deduce if lysis had gone to completion and if maximal luciferase activity was obtained, after the 16-min time point read both the nonmixed and the mixed plate sets were subjected to a 1-min mix step followed by a final read on the CLIPR™ 18 min after initial reagent addition. Under no circumstances was additional Britelite™ added.
RESULTS AND DISCUSSION
Several notable initial observations can be made by comparing the 96-well ( Fig. 1A-G ) and 384-well ( Fig. 2A-G ) microplate mixing results with the luciferase reporter data obtained using the standard homogeneous luciferase assay protocol, which lacks an orbital mixing step. First, regardless of the microplate format, it is apparent that at all 3 subconfluent cell densities (≤ 30,000 cells/96 well and ≤ 10,000 cells/384 well), cell lysis was essentially complete within 3 min in the absence of an additional mix step, yielding a linear luciferase activity profile for those 3 cell density points ( Figs. 1A and 2A) . Furthermore, although their signal intensities steadily decreased coincident with the half-life of the Britelite™ formulation, the linearity of the subconfluent cell density points was maintained throughout the time course. However, at the highest cell densities tested in both the 96-and 384-well format, which correspond to the common assay endpoint practice of allowing cells to become confluent prior to assessing their activity, the standard, no-mix protocol of add-wait-and-read resulted in an overall curvilinear response especially pronounced in the 96-well data set. In contrast, the luciferase activity plots for the parallel set of plates that were mixed immediately following addition of the same volume of Britelite™ remain relatively linear even when cells are permitted to grow to confluence ( Figs. 1B and 2B) . These results point to incomplete lysis at high cell densities rather than to insufficient substrate or incubation time as the source of the curvilinear profiles of the nonmixed samples because equal amounts of lysis buffer were employed in both no-mix and mix experiments, and even waiting as long as 15 min following reagent addition was insufficient for complete lysis of the confluent cultures in the absence of mixing ( Figs. 1A and 2A, 15 -min points). To confirm inadequate lysis as the cause of suboptimal signal levels at high cell densities, a final mix-and-read step was performed 18 min following reagent addition in which a linear profile was restored to the samples initially left unmixed (see 18-min time point, Figs. 1A and 2A) . For the high cell density samples that had been mixed immediately upon dispensing Britelite™ to the wells, no signal boost was observed following the final mix-and-read step, thus verifying that the initial mix step was sufficient for complete lysis of the confluent wells. In addition to assessing the impact that inclusion of a brief orbital mixing step had on signal levels and well-to-well signal variance in NIH 3T3 cells, 3 other cell types were tested in the 96-well format, including human colon carincoma RKO, human colon carcinoma SW480, and human cervix adenocarcinoma HeLa cells with similar results (data not shown), suggesting the utility of prophylactically incorporating this step in a variety of luciferase-based assays.
Paradoxically, although inclusion of an orbital mixing step was clearly necessary for maximal luciferase signal generation from the high cell density cultures, the mixed subconfluent cultures generally yielded modestly lower signals than their nonmixed counterparts. One possible explanation for this result is that in addition to facilitating more complete cell lysis and reaction mixing, too much orbital shaking may actually accelerate the kinetics of luminescent signal decay and/or the FIG. 1. Orbital mixing improves cell-based reporter assay outcome in the 96-well microplate format. NIH 3T3 cells stably expressing luciferase were seeded onto 96-well microplates at 4 different plating densities in final 100-µL volumes and allowed to adhere to the microplates during an overnight incubation to yield final confluencies of ~15% (7500 cells/96-well seeding),~30% (15,000 cells/96-well seeding),~60% (30,000 cells/ 96-well seeding), and ~100% (60,000 cells/96-well seeding). To assay for luciferase activity, an equal volume (100 µL) of Britelite™ (PerkinElmer, Boston, MA) assay reagent was dispensed onto each well using a Multidrop384 (Thermo Electron, Waltham, MA). Luminescence activity was determined using a CLIPR™ (Molecular Dynamics, Sunnyvale, CA). degradation of the catalytically active enzyme population 9, 10, 12, 14 such that there is a cell density-dependent mix time balance that must be met for optimal results.
To ascertain whether inclusion of a microplate orbital mixing step improves luciferase reporter assay precision, we calculated the average coefficient of variance (displayed as %CV) for each assayed condition. With the exception of the 30,000 cells/96-well condition, orbital mixing provided little or no substantial improvement in assay precision for the subconfluent cultures in either microplate format tested (compare Fig. 1C,D   FIG. 2. Orbital mixing improves cell-based reporter assay outcome in the 384-well microplate format. NIH 3T3 cells stably expressing luciferase were seeded onto 384-well microplates at 4 different plating densities in final 30-µL volumes and allowed to adhere to the microplates during an overnight incubation to yield final confluencies of ~15% (2500 cells/384-well seeding),~30% (5000 cells/384-well seeding),~60% (10,000 cells/384-well seeding), and ~100% (20,000 cells/384-well seeding). To assay for luciferase activity, an equal volume (30 µL) of Britelite™ (PerkinElmer, Boston, MA) assay reagent was dispensed onto each well using a uFill microplate dispenser (BioTek, Winooski, VT). Luminescence activity was determined using a CLIPR™ (Molecular Dynamics, Sunnyvale, CA). and separately Fig. 2C,D) . However, at high cell densities giving maximal signal, which would be the normal endpoint for most assays, orbital mixing of 96-and 384-well luciferase assay plates resulted in markedly improved assay precision, as evidenced by average %CV values as low as 2%. At the highest cell density tested in the 96-well format, average CVs were reduced from roughly 11% to just over 2% by initial orbital mixing. Although less dramatic, initial orbital mixing decreased the average CV in the 384-well format, depending on the time point considered, from roughly 4% in the nonmixed samples to roughly 2% in the mixed samples, which would still improve the Z score for an assay incorporating an initial orbital mixing step. Moreover, substantially improving assay precision by implementation of an orbital mixing step should, on average, lead to higher quality high-throughput screening (HTS) assays with better Z factors. 15 Imaging of the wells in nonmixed 96-and 384-well plates run under recommended assay conditions and viewed 3 min after reagent addition ( Figs. 1E and 2E) , as compared to plates initially mixed for 1 min and imaged 3 min postaddition ( Figs. 1G and 2G) , reveals spotty or punctuate luciferase development in the unmixed plates. Even after 15 min, the distribution of the luminescence within the wells remains relatively uneven among the nonmixed samples ( Figs. 1F and 2F) . Multiple factors likely contribute to the uneven signal emission patterns obtained from the nonmixed wells, including patchiness of cell growth within the wells, luminescence microgradient/ microenvironment effects due to viscosity differences between growth media and Britelite™ reagent, and intermittent areas of incomplete cell lysis. Consequently, detection devices employing a plate mask to restrict light detection to certain areas of the well rather than the entire well would likely benefit even more from incorporation of an orbital mixing step because, as shown in Figures 1G and 2G , orbital mixing results in much more even distribution of light intensity across the entire well.
In summary, in this report we demonstrate that incorporating a microplate orbital mixing step into high-throughput cell-based reporter assays can improve readouts by facilitating maximal luciferase signal induction from high cell density-containing samples as well as by minimizing the effects of common sources of variation and thereby improving assay precision. Under tested conditions, it is clear that incorporation of an orbital mixing step between addition of Britelite™ and determination of relative light units can both increase signal levels and decrease well-towell variance at typical cell densities employed under routine assay conditions. Because HTS applications typically involve processing of thousands of wells, even minor improvements in assay performance can translate into large benefits for screen outcome. Additional advantages afforded by mixing-mediated decreases in assay variance include reducing the number of replicates required, minimizing false-positive and false-negative rates, and expediting processing of plates in continuous processing automation systems.
